Skip to content

Medical emergency? What to do

"Smokable" pain drugs promise faster action

3-RXPublished February 1, 20073 min read

Key points

  • All self-respecting painkillers these days offer "fast-acting relief," a promise we accept to mean anywhere from 15 minutes to more than an hour.
  • The Palo Alto, California-based company is developing drugs that can be "smoked," and, like nicotine in cigarettes, pass through the lungs and into the bloodstream almost instantly.
  • Alexza was formed by biotechnology entrepreneur Alejandro Zaffaroni, who also founded nicotine-patch developer Alza.
  • The company's lead product is a vaporized version of an old drug called prochlorperazine, which Alexza is developing for migraine headaches but is currently used in liquid, oral or suppository form to treat severe nausea.

All self-respecting painkillers these days offer "fast-acting relief," a promise we accept to mean anywhere from 15 minutes to more than an hour.

For Alexza Pharmaceuticals Inc., which is developing drugs for migraine, pain, panic and agitation, "fast" has to mean "within seconds."

The Palo Alto, California-based company is developing drugs that can be "smoked," and, like nicotine in cigarettes, pass through the lungs and into the bloodstream almost instantly.

"What makes this an exciting story is how broadly applicable the technology could prove to be," said Charles Duncan, an analyst at JMP Securities.

Alexza was formed by biotechnology entrepreneur Alejandro Zaffaroni, who also founded nicotine-patch developer Alza. His latest venture is not the only company that is developing inhaled therapies: Nektar Therapeutics and Alkermes Inc. develop powdered insulin.

But Alexza's idea of heating up a drug to create a vapor, or smoke, is unique.

The company's lead product is a vaporized version of an old drug called prochlorperazine, which Alexza is developing for migraine headaches but is currently used in liquid, oral or suppository form to treat severe nausea.

While it is sometimes given intravenously in hospitals to treat patients with acute migraines, the drug is inconvenient to deliver.

HIP FLASK INHALERS

Alexza is hoping to provide similar results but in such a way that patients can carry the delivery device -- an inhaler that looks like a miniature hip flask -- in a pocketbook or the glove compartment of a car.

The device contains a battery-powered package that heats a thin coating of drug to create a vapor that can be sucked into the lungs.

"It's a useful mode of delivery, though its desirability and frequency of prescription will depend on the disorder," said Dr. Jeffrey Lieberman, chairman of psychiatry at Columbia University.

The company plans to release initial results of a mid-stage clinical trial of its migraine drug by the end of March. If all goes according to plan, Alexza could file a marketing application with U.S. regulators in 2010.

The company is also testing inhalable drugs for pain and anxiety, and for agitation in schizophrenia patients.

While Lieberman doubts there would be much demand for an inhaled product for agitated schizophrenia patients, who would be unlikely to cooperate in taking it, he said there could be benefit for patients with migraine, panic and pain.

"People with panic disorder want immediate relief and would be very cooperative," Lieberman said. "They know that if they take a pill it can take up to an hour to work. This would be a non-stigmatizing way to deal with the situation."

Thomas King, Alexza's chief executive, said the company expects to announce a partnership with either a major drugmaker or specialty pharmaceutical or device company to help develop at least one drug during the second half of this year.

"The key is to find partners with the same passion for the technology and what it conveys as we do," he said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug NewsPain

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.